Synopsis
0
JDMF
0
KDMF
0
VMF
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Thickeners and Stabilizers
Lubricants & Glidants
Fillers, Diluents & Binders
Coating Systems & Additives
Empty Capsules
Emulsifying Agents
Solubilizers
Film Formers & Plasticizers
Topical
Rheology Modifiers
Coloring Agents
Taste Masking
Granulation
Surfactant & Foaming Agents
Direct Compression
Controlled & Modified Release
Parenteral
Co-Processed Excipients
Disintegrants & Superdisintegrants
API Stability Enhancers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Sodium Dicloxacillin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Dicloxacillin, including repackagers and relabelers. The FDA regulates Sodium Dicloxacillin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Dicloxacillin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Dicloxacillin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Dicloxacillin supplier is an individual or a company that provides Sodium Dicloxacillin active pharmaceutical ingredient (API) or Sodium Dicloxacillin finished formulations upon request. The Sodium Dicloxacillin suppliers may include Sodium Dicloxacillin API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Dicloxacillin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Dicloxacillin DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Dicloxacillin active pharmaceutical ingredient (API) in detail. Different forms of Sodium Dicloxacillin DMFs exist exist since differing nations have different regulations, such as Sodium Dicloxacillin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Dicloxacillin DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Dicloxacillin USDMF includes data on Sodium Dicloxacillin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Dicloxacillin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Dicloxacillin suppliers with USDMF on PharmaCompass.
A Sodium Dicloxacillin CEP of the European Pharmacopoeia monograph is often referred to as a Sodium Dicloxacillin Certificate of Suitability (COS). The purpose of a Sodium Dicloxacillin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sodium Dicloxacillin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sodium Dicloxacillin to their clients by showing that a Sodium Dicloxacillin CEP has been issued for it. The manufacturer submits a Sodium Dicloxacillin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sodium Dicloxacillin CEP holder for the record. Additionally, the data presented in the Sodium Dicloxacillin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sodium Dicloxacillin DMF.
A Sodium Dicloxacillin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sodium Dicloxacillin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sodium Dicloxacillin suppliers with CEP (COS) on PharmaCompass.
A Sodium Dicloxacillin written confirmation (Sodium Dicloxacillin WC) is an official document issued by a regulatory agency to a Sodium Dicloxacillin manufacturer, verifying that the manufacturing facility of a Sodium Dicloxacillin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sodium Dicloxacillin APIs or Sodium Dicloxacillin finished pharmaceutical products to another nation, regulatory agencies frequently require a Sodium Dicloxacillin WC (written confirmation) as part of the regulatory process.
click here to find a list of Sodium Dicloxacillin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium Dicloxacillin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium Dicloxacillin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium Dicloxacillin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium Dicloxacillin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium Dicloxacillin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium Dicloxacillin suppliers with NDC on PharmaCompass.
Sodium Dicloxacillin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Dicloxacillin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Dicloxacillin GMP manufacturer or Sodium Dicloxacillin GMP API supplier for your needs.
A Sodium Dicloxacillin CoA (Certificate of Analysis) is a formal document that attests to Sodium Dicloxacillin's compliance with Sodium Dicloxacillin specifications and serves as a tool for batch-level quality control.
Sodium Dicloxacillin CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Dicloxacillin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Dicloxacillin may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Dicloxacillin EP), Sodium Dicloxacillin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Dicloxacillin USP).
LOOKING FOR A SUPPLIER?
